Almutairi M, Batran RA, Ussher JR
However, emerging evidence suggests a potential link between GLP-1 therapy and altered pain perception, possibly through several mechanisms: 1- Neuroinflammation and Microglial Activation: GLP-1 receptors are expressed in the brainstem, spinal cord, and dorsal root ganglia, regions involved in pain modulation
Later on, I found out, this was 2011 [00:14:00] University of Texas in Austin did a study on the liposome technology product of glirathione
They attached a fatty acid to GLP-1, which prolonged its action and produced greater weight loss than exenatide
In the trial nausea and diarrhoea were the most common side effects, but they were typically mild to moderate, transient and subsided over time
Fam Pract 23: 279285 Dror, D